Moderna
MRNA
#1534
Rank
โ‚น1.276 T
Marketcap
โ‚น3,266
Share price
6.91%
Change (1 day)
7.80%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: โ‚น1.276 Trillion

As of January 2026 Moderna has a market cap of โ‚น1.276 Trillion. This makes Moderna the world's 1534th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น1.276 T16.6%
2025โ‚น1.094 T-17.39%
2024โ‚น1.324 T-58.03%
2023โ‚น3.156 T-44.72%
2022โ‚น5.710 T-25.5%
2021โ‚น7.664 T153.51%
2020โ‚น3.023 T544.07%
2019โ‚น469.41 B33.71%
2018โ‚น351.06 B

End of Day market cap according to different sources

On Jan 12th, 2026 the market cap of Moderna was reported to be:

โ‚น1.193 Trillion
by Nasdaq info icon info icon
โ‚น1.193 Trillion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Regulus Therapeutics
RGLS
โ‚น50.99 B-96.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น24.490 T 1,819.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
โ‚น75.21 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น4.435 T 247.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น24.490 T 1,819.17%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Arrowhead Pharmaceuticals
ARWR
โ‚น855.71 B-32.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น46.343 T 3,531.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
โ‚น268.78 B-78.94%๐Ÿ‡บ๐Ÿ‡ธ USA